To date, dysregulation of the MEK pathway leading to increased cellular division and proliferation has been described to play a vital role in several broad categories of cancer, including melanoma, multiple myeloma, cholangiocarcinoma, pancreatic, lung, colorectal, breast, ovarian, testicular, and CNS tumors [3,72,73,74]. Here, MAP2K7 is linked to cancer.